Total Payments
$15,617
2024 Payments
$337.61
Companies
15
Transactions
80
Medicare Patients
805
Medicare Billing
$125,347
Payment Breakdown by Category
Consulting$7,560 (48.4%)
Travel$5,139 (32.9%)
Food & Beverage$2,917 (18.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $7,560 | 2 | 48.4% |
| Travel and Lodging | $5,139 | 22 | 32.9% |
| Food and Beverage | $2,917 | 56 | 18.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $6,098 | 14 | $0 (2020) |
| Biom'Up SA | $5,789 | 11 | $0 (2019) |
| Intuitive Surgical, Inc. | $2,118 | 26 | $0 (2021) |
| Genentech USA, Inc. | $334.04 | 3 | $0 (2019) |
| TESARO, Inc. | $249.99 | 2 | $0 (2019) |
| Dilon Technologies, Inc. | $171.98 | 2 | $0 (2023) |
| Covidien LP | $141.49 | 1 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $134.30 | 2 | $0 (2024) |
| Merck Sharp & Dohme LLC | $123.14 | 6 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $114.72 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $337.61 | 10 | AstraZeneca Pharmaceuticals LP ($110.00) |
| 2023 | $393.33 | 9 | Dilon Technologies, Inc. ($171.98) |
| 2022 | $16.91 | 1 | Myriad Genetic Laboratories, Inc. ($16.91) |
| 2021 | $140.26 | 3 | Myriad Genetic Laboratories, Inc. ($97.81) |
| 2020 | $5,998 | 13 | Pacira Pharmaceuticals Incorporated ($5,964) |
| 2019 | $6,527 | 19 | Biom'Up SA ($5,789) |
| 2018 | $1,299 | 16 | Intuitive Surgical, Inc. ($1,158) |
| 2017 | $903.88 | 9 | Intuitive Surgical, Inc. ($903.88) |
All Payment Transactions
80 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/21/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $27.30 | General |
| Category: ONCOLOGY | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $110.00 | General |
| Category: Oncology | ||||||
| 09/04/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $33.93 | General |
| Category: Oncology | ||||||
| 08/21/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $27.96 | General |
| Category: ONCOLOGY | ||||||
| 08/21/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $27.67 | General |
| Category: ONCOLOGY | ||||||
| 08/07/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: Oncology | ||||||
| 07/03/2024 | TELA Bio, Inc. | OviTex 2S (Device) | Food and Beverage | In-kind items and services | $31.84 | General |
| Category: Surgical Mesh | ||||||
| 07/03/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: ONCOLOGY | ||||||
| 05/29/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $20.74 | General |
| 10/18/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: ONCOLOGY | ||||||
| 10/07/2023 | ImmunoGen, Inc. | Elahere (Biological) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Oncology | ||||||
| 10/03/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: ONCOLOGY | ||||||
| 09/06/2023 | OsteoCentric Technologies, Inc. | OsteoCentric 4.0 x 130mm LOCKING BONE SCREW FASTENER ST (Device) | Food and Beverage | Cash or cash equivalent | $97.19 | General |
| Category: Not Applicable | ||||||
| 09/06/2023 | Dilon Technologies, Inc. | HEMOBLAST BELLOWS (Device) | Food and Beverage | In-kind items and services | $87.82 | General |
| Category: HEMOSTATIC AGENT | ||||||
| 08/15/2023 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: Oncology | ||||||
| 05/05/2023 | Dilon Technologies, Inc. | HEMOBLAST BELLOWS (Device) | Food and Beverage | In-kind items and services | $84.16 | General |
| Category: HEMOSTATIC AGENT | ||||||
| 02/21/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LENVIMA | Food and Beverage | In-kind items and services | $30.21 | General |
| Category: ONCOLOGY | ||||||
| 07/20/2022 | Myriad Genetic Laboratories, Inc. | myRisk (Device) | Food and Beverage | Cash or cash equivalent | $16.91 | General |
| Category: Germline DNA Sequencing Hereditary Cancer and Rearrangement Analysis | ||||||
| 07/13/2021 | Myriad Genetic Laboratories, Inc. | myChoice CDx (Device) | Food and Beverage | Cash or cash equivalent | $97.81 | General |
| Category: Tumor DNA Genetic Oncology Analysis | ||||||
| 04/15/2021 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $20.82 | General |
| Category: Oncology | ||||||
| 02/04/2021 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: SURGERY | ||||||
| 05/28/2020 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Consulting Fee | Cash or cash equivalent | $4,060.00 | General |
| Category: PAIN MANAGEMENT | ||||||
| 05/28/2020 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Travel and Lodging | Cash or cash equivalent | $872.40 | General |
| Category: PAIN MANAGEMENT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 190 | 357 | $158,382 | $29,152 |
| 2022 | 6 | 203 | 316 | $178,923 | $34,032 |
| 2021 | 7 | 227 | 331 | $190,315 | $39,665 |
| 2020 | 4 | 185 | 324 | $117,166 | $22,499 |
Total Patients
805
Total Services
1,328
Medicare Billing
$125,347
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 145 | 309 | $132,870 | $24,807 | 18.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 22 | 22 | $14,306 | $2,512 | 17.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2023 | 11 | 13 | $5,603 | $1,083 | 19.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 12 | 13 | $5,603 | $749.97 | 13.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 117 | 220 | $94,600 | $18,184 | 19.2% |
| 58571 | Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | Facility | 2022 | 11 | 11 | $43,758 | $8,416 | 19.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 29 | 29 | $17,023 | $3,099 | 18.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 13 | 13 | $8,229 | $1,618 | 19.7% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2022 | 14 | 20 | $8,620 | $1,518 | 17.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 19 | 23 | $6,693 | $1,197 | 17.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 94 | 182 | $70,952 | $15,218 | 21.4% |
| 58571 | Abdominal removal of uterus (250 grams or less) with removal of tubes and/or ovaries using an endoscope | Facility | 2021 | 12 | 12 | $49,526 | $9,683 | 19.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 24 | 36 | $20,142 | $4,610 | 22.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 26 | 26 | $14,848 | $2,965 | 20.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 18 | 18 | $13,590 | $2,901 | 21.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 42 | 46 | $11,074 | $2,631 | 23.8% |
| 38900 | Lymph node imaging during surgery | Facility | 2021 | 11 | 11 | $10,183 | $1,657 | 16.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 124 | 252 | $86,282 | $15,862 | 18.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 24 | 24 | $13,536 | $2,674 | 19.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 20 | 28 | $13,574 | $2,600 | 19.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 17 | 20 | $3,774 | $1,363 | 36.1% |
About Dr. Jill Tseng, M.D
Dr. Jill Tseng, M.D is a Gynecologic Oncology healthcare provider based in Orange, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/21/2010. The National Provider Identifier (NPI) number assigned to this provider is 1265759807.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jill Tseng, M.D has received a total of $15,617 in payments from pharmaceutical and medical device companies, with $337.61 received in 2024. These payments were reported across 80 transactions from 15 companies. The most common payment nature is "Consulting Fee" ($7,560).
As a Medicare-enrolled provider, Tseng has provided services to 805 Medicare beneficiaries, totaling 1,328 services with total Medicare billing of $125,347. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecologic Oncology
- Location Orange, CA
- Active Since 04/21/2010
- Last Updated 09/13/2018
- Taxonomy Code 207VX0201X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1265759807
Products in Payments
- EXPAREL (Drug) $6,098
- HEMOBLAST (Device) $5,448
- Da Vinci Surgical System (Device) $2,118
- Hemoblast (Device) $340.62
- Avastin (Biological) $334.04
- ZEJULA (Drug) $249.99
- HEMOBLAST BELLOWS (Device) $171.98
- LigaSure (Device) $141.49
- ENHERTU (Biological) $110.00
- KEYTRUDA (Biological) $102.40
- Lenvima (Drug) $98.77
- myChoice CDx (Device) $97.81
- OsteoCentric 4.0 x 130mm LOCKING BONE SCREW FASTENER ST (Device) $97.19
- JEMPERLI (Biological) $96.86
- OviTex 2S (Device) $31.84
- LYNPARZA (Drug) $24.30
- Elahere (Biological) $17.47
- myRisk (Device) $16.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gynecologic Oncology Doctors in Orange
Dr. Krishnansu Tewari, M.d, M.D
Gynecologic Oncology — Payments: $638,710
Gynecologic Oncology $638,710
Fabio Cappuccini, Md, MD
Gynecologic Oncology — Payments: $310,665
Gynecologic Oncology $310,665
Michael L Berman, Md, MD
Gynecologic Oncology — Payments: $393.37
Gynecologic Oncology $393.37
Mark Rettenmaier, M.d, M.D
Gynecologic Oncology
Gynecologic Oncology
Dr. Danielle Jandial
Gynecologic Oncology
Gynecologic Oncology
Lila Marshall
Gynecologic Oncology
Gynecologic Oncology